BB Biotech (Switzerland) Analysis
| BION Stock | CHF 33.05 0.10 0.30% |
BB Biotech AG is undervalued with Real Value of 37.58 and Hype Value of 33.05. The main objective of BB Biotech stock analysis is to determine its intrinsic value, which is an estimate of what BB Biotech AG is worth, separate from its market price. There are two main types of BB Biotech's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect BB Biotech's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of BB Biotech's stock to identify patterns and trends that may indicate its future price movements.
The BB Biotech stock is traded in Switzerland on SIX Swiss Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Switzerland. BB Biotech is usually not traded on Good Friday, Berchtoldstag, Easter Monday, International Workers ' Day, Ascension Day ( 2025 ), Whitmonday ( 2025 ), National Day, Christmas Eve ( 2025 ), Christmas Day, St . Stephen 's Day, New Year 's Eve ( 2025 ), New Year 's Day. BION Stock trading window is adjusted to Europe/Zurich timezone.
BION |
BION Stock Analysis Notes
The company has price-to-book (P/B) ratio of 1.28. Some equities with similar Price to Book (P/B) outperform the market in the long run. BB Biotech AG recorded a loss per share of 16.73. The entity last dividend was issued on the 27th of March 2023. The firm had 5:1 split on the 29th of March 2016. BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland. BB BIOTECH operates under Pharmaceuticals And Biosciences classification in Switzerland and is traded on Switzerland Exchange. For more info on BB Biotech AG please contact the company at 41 44 267 67 00 or go to https://www.bbbiotech.ch/en/bb-biotech/.BB Biotech AG Investment Alerts
| BB Biotech AG has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (404.81 M) with profit before overhead, payroll, taxes, and interest of 4 K. | |
| BB Biotech AG has accumulated about 2.83 M in cash with (94.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 65.76, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
BB Biotech Thematic Classifications
In addition to having BB Biotech stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | ITInformation technology and IT services |
BION Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.15 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BB Biotech's market, we take the total number of its shares issued and multiply it by BB Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 21st of July, BB Biotech owns the Standard Deviation of 1.58, market risk adjusted performance of 3.26, and Coefficient Of Variation of 486.56. BB Biotech AG technical analysis gives you the methodology to make use of past data patterns to determine a pattern that approximates the direction of the entity's future prices. Please confirm BB Biotech AG semi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation to decide if BB Biotech AG is priced fairly, providing market reflects its prevailing price of 33.05 per share.BB Biotech AG Price Movement Analysis
The output start index for this execution was eleven with a total number of output elements of fifty. The Simple Moving Average indicator is calculated by adding the closing price of BB Biotech for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out BB Biotech AG short-term fluctuations and highlight longer-term trends or cycles.
BB Biotech Outstanding Bonds
BB Biotech issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. BB Biotech AG uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most BION bonds can be classified according to their maturity, which is the date when BB Biotech AG has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
BB Biotech Predictive Daily Indicators
BB Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BB Biotech stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
BB Biotech Forecast Models
BB Biotech's time-series forecasting models are one of many BB Biotech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BB Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About BION Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how BB Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BION shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as BB Biotech. By using and applying BION Stock analysis, traders can create a robust methodology for identifying BION entry and exit points for their positions.
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland. BB BIOTECH operates under Pharmaceuticals And Biosciences classification in Switzerland and is traded on Switzerland Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding BB Biotech to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
Additional Tools for BION Stock Analysis
When running BB Biotech's price analysis, check to measure BB Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BB Biotech is operating at the current time. Most of BB Biotech's value examination focuses on studying past and present price action to predict the probability of BB Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BB Biotech's price. Additionally, you may evaluate how the addition of BB Biotech to your portfolios can decrease your overall portfolio volatility.